Leaderboards/Pharmacology and Obesity Treatment

Pharmacology and Obesity Treatment

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Mohit Sodhi
University of British Columbia
2
Salma Mostafa Mohamed
Cairo University
3
Jennifer H. Hwang
University of Illinois Chicago
4
Fatima Quddos
Biomedical Research Institute
5
Christiane Lundegaard Haase
Novo Nordisk (Denmark)
6
Farhad Mehrtash
Harvard University
7
Lamija Ferhatbegović
Voronezh State Medical Academy named after N.N. Burdenko
8
Samantha Anderer
Evanston Hospital
9
Femin Prasad
Centre for Addiction and Mental Health
10
Christos P. Kotanidis
University of Oxford

Papers

1
Publication in JAMA Health Forum (2025) [60 citations, W4408468512]
JAMA Health Forum|2025
60 cit.
2
Publication in JAMA Health Forum (2025) [31 citations, W4409783245]
JAMA Health Forum|2025
31 cit.
3
Vitis vinifera L. seed standardized extract; a promising therapeutic against metabolic syndrome induced by high-fat/high-carbohydrate diet and streptozotocin in rats
South African Journal of Botany|2024
13 cit.
4
Publication in Scientific Reports (2025) [6 citations, W4415208770]
Scientific Reports|2025
6 cit.
5
Publication in Drug and Alcohol Dependence (2024) [W4400575474]
Drug and Alcohol Dependence|2024
0 cit.
6
Publication in Atherosclerosis (2024) [W4401601030]
Atherosclerosis|2024
0 cit.
7
Publication in Atherosclerosis (2025) [W4413268692]
Atherosclerosis|2025
0 cit.
8
Publication in Acta Clinica Croatica (2025) [W4416168101]
Acta Clinica Croatica|2025
0 cit.
9
Publication in Obesity (2026) [W7131129422]
Obesity|2026
0 cit.
10
Publication in Harm Reduction Journal (2026) [W7132828336]
Harm Reduction Journal|2026
0 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Sonja Wicklum
University of Calgary
2
Katharina Schütt
RWTH Aachen University
3
Nusrat Jahan
Soonchunhyang University
4
Tammy Forrester
Eli Lilly (United States)
5
Seung-Hee Hong
Guideline Geo (Sweden)
6
Szu Shen Wong
Keele University
7
Perica Davitkov
Case Western Reserve University
8
Riham A. El‐Shiekh
Cairo University
9
Alaa F. Bakr
Cairo University
10
Sue D. Pedersen
Ted Rogers Centre for Heart Research

Papers

1
The Concise Guide to PHARMACOLOGY 2023/24: Enzymes
British Journal of Pharmacology|2023
439 cit.
2
Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial
Nature Medicine|2023
390 cit.
3
AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity
Gastroenterology|2022
299 cit.
4
Metabolic syndrome: risk factors, diagnosis, pathogenesis, and management with natural approaches
Food Chemistry Advances|2023
222 cit.
5
Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
New England Journal of Medicine|2025
94 cit.
6
AGA Clinical Practice Guideline on Endoscopic Eradication Therapy of Barrett’s Esophagus and Related Neoplasia
Gastroenterology|2024
72 cit.
7
<i>Lepidium meyenii</i> (Maca) Roots: UPLC-HRMS, Molecular Docking, and Molecular Dynamics
ACS Omega|2022
29 cit.
8
Hypericum perforatum L. Nanoemulsion Mitigates Cisplatin-Induced Chemobrain via Reducing Neurobehavioral Alterations, Oxidative Stress, Neuroinflammation, and Apoptosis in Adult Rats
Toxics|2023
24 cit.
9
The ‘10 commandments’ for the 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
European Heart Journal|2024
24 cit.
10
Synthesis and molecular docking simulation of new benzimidazole–thiazole hybrids as cholinesterase inhibitors
Archiv der Pharmazie|2023
22 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Sidney C. Smith
University of North Carolina at Chapel Hill
2
Michael Gnant
Austrian Breast & Colorectal Cancer Study Group
3
Eduardo Ortíz
Hospital Universitario Virgen del Rocío
4
Hermann Toplak
Medical University of Graz
5
Barry Braun
Colorado State University
6
Guillermo E. Umpierrez
Emory University
7
Wesley Day
Yale University
8
Ulf Smith
University of Gothenburg
9
Hartzell V. Schaff
Mayo Clinic in Arizona
10
Steven B. Heymsfield
Pennington Biomedical Research Center

Papers

1
Harmonizing the Metabolic Syndrome
Circulation|2009
14.7k cit.
2
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
The Lancet|1994
8.5k cit.
3
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
The Lancet|1998
8.4k cit.
4
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults
JAMA|2013
8k cit.
5
ACC/AHA Guidelines for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction: Executive Summary and Recommendations
Circulation|2000
4.5k cit.
6
European Guidelines for Obesity Management in Adults
Obesity Facts|2015
3.4k cit.
7
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention—Summary Article
Circulation|2006
2.2k cit.
8
Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
PubMed|1998
2.2k cit.
9
Hyperglycemia: An Independent Marker of In-Hospital Mortality in Patients with Undiagnosed Diabetes
The Journal of Clinical Endocrinology & Metabolism|2002
2.1k cit.
10
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
Circulation|2006
2.1k cit.

Reagents for Pharmacology and Obesity Treatment

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

Cell Signaling Technology

RBC Lysis Buffer (10X)

#46232$80
View Evidence →

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 66

Phospho-Bim (Ser77) (D4H12) Rabbit Monoclonal Antibody

#12433$176,415
View Evidence →
Cell Signaling Technology

NETosis Antibody Sampler Kit

#90144$509
View Evidence →
Cell Signaling TechnologyEvidence 65

Cleaved Lamin A (Small Subunit) (30H5) Mouse Monoclonal Antibody

#2036$179,411
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 63

Phospho-RPA32/RPA2 (Ser33) (E9N1T) Rabbit Monoclonal Antibody

Cited in 8 papers
#10148$176,415
View Evidence →
Cell Signaling TechnologyEvidence 63

Androgen Receptor (E9L1Z) Rabbit Monoclonal Antibody (Carboxy-terminal Antigen) (BSA and Azide Free)

Cited in 8 papers
#54524$865
View Evidence →
Cell Signaling TechnologyEvidence 66

ELMO1 (D4K2E) Rabbit Monoclonal Antibody

#14457$161,351
View Evidence →